Cite
HARVARD Citation
Zheng, R. et al. (2023). Combining chemotherapy and tislelizumab with preoperative split-course hypofraction radiotherapy for locally advanced rectal cancer: study protocol of a prospective, single-arm, phase II trial. BMJ open. 13 (3), p. . [Online].